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Abstract
The adapter molecule CAS is localized primarily within focal adhesions in fibroblasts. Because many of the cellular
functions attributed to CAS are likely to be dependent on its presence in focal adhesions, this study was undertaken to
identify regions of the protein that are involved in its localization. The SH3 domain of CAS, when expressed in isolation from
the rest of the protein, was able to target to focal adhesions, whereas a variant containing a point mutation that rendered the
SH3 domain unable to associate with FAK remained cytoplasmic. However, in the context of full-length CAS, this mutation
did not prevent CAS localization to focal adhesions. Two other variants of CAS that contained deletions of either the SH3
domain alone, or the SH3 domain together with an adjoining proline-rich region, also retained the capacity to localize to
focal adhesions. A second focal adhesion targeting region was mapped to the extreme carboxy terminus of CAS. The
identification of this second focal adhesion targeting domain in CAS ascribes a previously unknown function to the highly
conserved C terminus of CAS. The regulated targeting of CAS to focal adhesions by two independent domains may reflect
the important role of CAS within this subcellular compartment. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
p130Cas (CAS) was initially identi¢ed as a highly
tyrosine phosphorylated protein in v-src and v-crk
transformed cells [1^3]. In normal ¢broblasts, CAS
is localized predominantly to focal adhesions [4,5].
0167-4889 / 00 / $ ^ see front matter ß 2000 Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 7 - 4 8 8 9 ( 0 0 ) 0 0 1 0 4 - X
Abbreviations: CAS, crk-associated substrate; FAK, focal adhesion kinase; HEF1, human enhancer of ¢lamentation 1; Efs, embry-
onal fyn-associated substrate; Sin, Src interacting protein; SH3, Src homology 3 domain; SH2, Src homology 2 domain; C terminus,
carboxy terminus; N terminus, amino terminus; PI3K, phosphatidylinositol 3-kinase; PLCQ, phospholipase CQ ; GST, glutathione S-
transferase; REF, rat embryo ¢broblast; CE, chicken embryo; FBS, fetal bovine serum; DMEM, Dulbecco’s modi¢ed Eagle’s medium;
PCR, polymerase chain reaction; PBS, phosphate-bu¡ered saline; BSA, bovine serum albumin; RT, room temperature; mAb, mono-
clonal antibody; FITC, £uorescein isothiocyanate; RIPA, radioimmunoprecipitation assay; HRP, horseradish peroxidase; SDS-PAGE,
sodium dodecyl sulfate-polyacrylamide gel electrophoresis ; ECL, enhanced chemiluminescence; ECM, extracellular matrix; pTyr, phos-
photyrosine; PTP, protein tyrosine phosphatase; JNK, Jun N-terminal kinase
* Corresponding author. Fax: (804) 9821071; E-mail : ahb8y@virginia.edu
1 Present address: Department of Biochemistry and Biotechnology Institute, Trinity College, Dublin 2, Ireland.
BBAMCR 14688 6-12-00
Biochimica et Biophysica Acta 1499 (2000) 34^48
www.elsevier.com/locate/bba
Integrin receptors and a variety of structural and
signaling molecules become clustered at focal adhe-
sions during cell adhesion, and act to mediate the
attachment of actin stress ¢bers at these sites [6].
CAS, along with two other proteins, HEF1 [7] and
Efs/Sin [8,9], constitute a family of structurally re-
lated adapter proteins. All three possess a highly
conserved amino-terminal (N-terminal) Src homol-
ogy 3 (SH3) domain. This is followed by a proline-
rich region in CAS. All have a central substrate bind-
ing domain (YXXP) of varying length composed of a
cluster of potential Src homology 2 (SH2) interaction
sites. In CAS, the majority of these sites conform to
the YDXP consensus sequence for Crk/Nck binding.
In the carboxy terminus (C terminus) of all three
molecules, a consensus binding site for the SH2 do-
main of Src (YDYV) is absolutely conserved. In ad-
dition, a consensus binding site for the SH3 domain
of Src is present in CAS and Efs just upstream from
the Src SH2 domain binding site. A region at the
extreme C terminus, which is also conserved in all
three molecules, contains a helix-loop-helix motif
[10].
On the basis of its structure, it is proposed that
CAS functions within focal adhesions as a sca¡old-
ing protein, enabling the assembly of macromolecu-
lar signaling complexes. CAS associates with both
FAK and Src, the two major tyrosine kinases impli-
cated in integrin-mediated signaling. FAK binds to
the SH3 domain of CAS [4,11]. The guanine nucle-
otide exchange factor C3G and two protein tyrosine
phosphatases, PTP-PEST and PTP-1B, can also bind
to this domain [12^14]. The interaction between Src
and CAS is mediated by a bipartite binding site lo-
cated in the C terminus of CAS that has speci¢city
for both the SH3 and SH2 domains of Src [15,16].
CAS is one of a limited number of proteins within
focal adhesions that become tyrosine phosphorylated
upon adhesion to the extracellular matrix (ECM)
[4,5,17,18]. In Src null cells, the adhesion-dependent
tyrosine phosphorylation of CAS is abrogated,
whereas in cells deleted for FAK, CAS phosphory-
lation appears normal [19^21]. Overexpression of
FAK does, however, result in an increase in the level
of tyrosine phosphorylation of CAS, and this was
shown to be dependent on the presence of a Src
binding site on FAK, but not on FAK kinase activ-
ity per se [22]. Thus, FAK may play an indirect role
in CAS phosphorylation by binding to, and activat-
ing, Src [23,24]. The SH2 domains of a variety of
signaling molecules have been shown to associate
with CAS in an adhesion-dependent manner. These
include Crk, Nck, PI3K, PLCQ and Grb2 [20]. Re-
cently a new class of adapter molecules that are com-
posed of an N-terminal SH2 domain and a proline/
serine-rich domain (NSP proteins) have also been
shown to associate with CAS [25]. Analysis of the
mouse form of NSP3/Chat [26] revealed that this
protein interacts with the highly conserved C-termi-
nal domain of CAS. Overexpression of both NSP1
and Chat has been reported to induce activation of
Jun N-terminal kinase (JNK) activity [25,26].
Recent studies have provided insight into the role
of CAS within focal adhesions. Translocation of the
virulence factor YopH, a protein tyrosine phospha-
tase (PTP) produced by the pathogenic bacteria Yer-
sinia, into mammalian cells causes disassembly of
focal adhesions [27,28]. This translocation results in
the selective dephosphorylation of CAS with kinetics
that parallel the breakdown of focal adhesions. In
contrast, translocation of a catalytically inactive
‘substrate-trapping’ mutant of YopH correlates
with an increase in phosphotyrosine (pTyr) on CAS
and stabilization of focal adhesions [27,28]. Similar
to the e¡ect of this YopH mutant, cells in which the
gene encoding PTP-PEST is disrupted display a con-
stitutive increase in tyrosine phosphorylation of
CAS, and a corresponding increase in the number
and size of focal adhesions. This correlates with a
strong defect in motility, and the ability of these
PTP-PEST 3/3 cells to spread faster when plated
on ¢bronectin [29,30].
Several studies have implicated CAS as playing a
key role in cell migration. Fibroblasts isolated from
mouse embryos that contain a genomic disruption of
CAS exhibit signi¢cant defects in cell migration and
cell spreading as compared to null cells engineered to
re-express CAS [31]. These CAS-de¢cient ¢broblasts
are also impaired in actin stress ¢ber formation, im-
plying that CAS is required for this process [32].
Secondly, overexpressed FAK promotes cell migra-
tion in Chinese hamster ovary cells, and this is de-
pendent on its association with CAS [22]. Finally,
overexpression of CAS can promote cell migration
in certain cell types through the establishment of
CAS/Crk complexes that regulate motility by pro-
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moting membrane ru¥ing [33,34]. CAS, Crk and
Chat have all been shown to colocalize with actin
¢laments at ru¥ing membranes in migrating cells
[26,34]. Thus, the evidence to date suggests that
CAS plays a key role in focal adhesion formation
and cell migration.
In light of the important functions that CAS ap-
pears to play within focal adhesions, this study was
undertaken to identify the domains of CAS that are
involved in its localization. We demonstrate that two
domains are important for targeting CAS to focal
adhesions, the SH3 domain and a highly conserved
domain at the extreme C terminus of CAS. Deletion
of both of these domains from CAS is necessary to
completely prevent its localization to focal adhesions.
These data agree in part with a previous study, which
showed that the SH3 domain was responsible for
targeting CAS to focal adhesions [35]. The identi¢-
cation of a second, extremely potent, focal adhesion
targeting domain in CAS ascribes a previously un-
known function to the highly conserved C terminus
of CAS. Perhaps more importantly, the presence of
two focal adhesion targeting sequences in CAS
underscores the critical importance of CAS localiza-
tion to these regions of the cell.
2. Materials and methods
2.1. Cell culture, transfection and microinjection
Rat embryo ¢broblast (REF52) cells were main-
tained in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS), penicillin (100 units/ml), and streptomycin
(100 Wg/ml) (Gibco, Rockville, MD). For immuno-
staining, cDNAs encoding CAS and CAS variants
were introduced into REF52 cells using either the
Superfect transfection reagent (Qiagen), or by micro-
injection. For transfection, the cDNA of interest was
used in the range of 500 ng^5 Wg per 6 cm dish. All
samples were made up to a total of 5 Wg of DNA
using vector, and transfections were carried out ac-
cording to the manufacturer’s directions. At approx.
5 h post transfection, the cells were trypsinized and
plated onto ¢bronectin-coated coverslips (2.5 Wg/
cm2). Cells were ¢xed for immunostaining at 18 h
post transfection.
Microinjection of cells was carried out as described
[36]. Brie£y, REF52 cells were plated at a density of
1U103 in a 10 Wl drop on an etched coverslip and
allowed to attach for 15 min at 37‡C in 7.5% CO2.
DMEM containing 10% FBS was added to the dish
and the cells were allowed to spread overnight. Dur-
ing microinjection, cells were maintained at 37‡C and
50^100 cells were injected within 15 min. Cells were
injected with plasmid DNA directly into the nuclei in
concentrations ranging from 2.5 to 100 ng/Wl in 10
mM Tris, 1 mM EDTA (pH 8). Post injection, cells
were returned to the incubator at 37‡C and 7.5%
CO2 for 1.5^3 h.
For immunoblotting and protein association as-
says, the cDNA constructs were introduced into ei-
ther 293 cells or COS-1 cells. 293 cells were main-
tained in DME/F12 (1:1) medium and COS-1 cells
were maintained in DMEM. In both cases the me-
dium was supplemented with 10% FBS, penicillin
(100 units/ml) and streptomycin (100 Wg/ml). Trans-
fection was carried out using either DEAE-dextran
or lipofectamine (Gibco) according to the manufac-
turer’s directions. For in vitro association assays ex-
amining the interaction between the CAS SH3 do-
main and FAK, chicken embryo (CE) cell lysate was
used. CE cells were prepared and cultured as de-
scribed previously [37].
2.2. Mutagenesis of CAS and construction of plasmids
Amino acids are numbered according to the short-
er splice form of CAS [1] (Fig. 1). The short form of
CAS was subcloned into pALTER, and the amino
acid substitutions E21Q, P642A and Y668F were
made either singly or in combination, using the Al-
tered sites in vitro mutagenesis system (Promega).
The presence of mutations was con¢rmed by DNA
sequencing. These constructs were subcloned into the
mammalian expression vector pRK5myc [38] at the
BamHI-XbaI sites.
Deletions were made within the short form of
CAS, which was previously cloned into the BamHI-
XbaI sites of pRK5myc [39]. The SH3 domain was
deleted by generating a polymerase chain reaction
(PCR) product commencing at codon 65 (vSH3).
The SH3 and proline regions were deleted by gener-
ating a PCR product commencing at codon 117
(vSH3/Pro). Both of these products were digested
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with BamHI, which recognized a site that was engi-
neered into the 5P PCR primer, and at the 3Pend with
NheI, which cuts at a unique site within CAS. The
corresponding BamHI-NheI wild-type fragment of
CAS was then replaced with the PCR-derived anal-
ogous restriction fragment. Amino acid residues 119^
421 in the substrate binding YXXP region were de-
leted by splicing together a PCR product encoding
the ¢rst 118 amino acids at the N terminus of CAS
with a PCR product encoding amino acids 422^780.
The PCR product encoding amino acids 1^118 was
digested with BamHI and SalI, which cut at sites
engineered into the 5P and 3P primers respectively.
The PCR product encoding amino acids 422^780
was digested with SalI, which cut at a site engineered
into the 5P PCR product, and BglII, which cut at a
unique site in CAS present on the PCR product.
Both of these digested PCR products were then li-
gated in a three-way ligation with pRK5mycCAS
digested with BamHI and BglII, thus replacing the
corresponding wild-type fragment of CAS. Construc-
tion of this deletion resulted in the creation of an
Asp residue at the splice junction. The C terminus
was deleted from amino acid 546 onwards (vCT[546^
874]) by digesting pRK5mycCAS or pRK5mycCA-
S(E21Q) with HindIII, which cuts within CAS and in
the multiple cloning site of pRK5myc, and then re-
ligating the plasmid. The carboxy terminus was de-
leted from amino acid 693 onwards (vCT[693^874])
by generating a PCR product that spanned amino
acids 544^692. This was spliced into full-length
CAS by digesting pRK5CAS with HindIII-XbaI,
and replacing it with the corresponding HindIII-
XbaI PCR fragment.
Each of the discrete regions of CAS, i.e. the SH3
domain (both the wild-type and the derivative con-
taining the E21Q amino acid substitution), the sub-
strate binding YXXP domain, and CT(693^874) were
generated as PCR products using primers corre-
sponding to the amino acids shown (Fig. 1). The
SH3 domain constructs and the CT construct were
subcloned in-frame into pRK5myc at the BamHI-
EcoRI sites. The substrate binding YXXP domain
was cloned in-frame into pCMVmyc at BamHI-
EcoRI sites. All constructs were veri¢ed by DNA
sequencing.
A glutathione S-transferase (GST) fusion of the
CAS SH3 domain mutated at E21Q was made as
described previously for the wild-type SH3 domain
[4]. The generation of the GST-CtermII(FAK) and
GST-SH3(Src) GST fusion proteins is described else-
where [4,40].
Fig. 1. Schematic representation of CAS and deletion variants.
Amino acids are designated by the numbers above the sche-
matic. The black rectangle represents the position of the myc
epitope tag. The SH3 domain is represented by the shaded
circle. The clear circle represents a region rich in proline resi-
dues. The substrate binding YXXP domain (YXXP), which
contains 15 copies of the amino acid motif given in single letter
code, is represented by the black oval. The C terminus of CAS
is shown by the shaded bar. The sites of interaction for the Src
SH3 and SH2 domain are indicated as RPLPSPP and YDYV
respectively.
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2.3. Antibodies
The myc epitope tag was detected using monoclo-
nal antibody (mAb) 9E10 (Santa Cruz Biotechnol-
ogy). FAK was detected using protein G-puri¢ed
polyclonal antibodies BC3 [41], and CAS was de-
tected using protein G-puri¢ed polyclonal antibodies
CAS-F [42].
2.4. Immuno£uorescence
REF52 cells were grown on coverslips, ¢xed in 3%
paraformaldehyde for 20 min, and washed three
times with calcium- and magnesium-free phosphate-
bu¡ered saline (PBS) before permeabilization for 5 min
in 0.25% Triton X-100. The slides were rewashed
with PBS to remove Triton X-100, and incubated
¢rst in 10% bovine serum albumin (BSA) in PBS
for 30 min followed by primary antibody in a solu-
tion of 2% BSA in PBS for 1 h at room temperature
(RT). The coverslips were then washed three times in
PBS for 5 min/wash to remove excess antibody and
incubated for 1 h with secondary antibody. mAb
9E10 was used at a concentration of 0.2 Wg/ml.
CAS-F was used at 2.7 Wg/ml and BC3 was used at
4 Wg/ml. Fluorescein isothiocyanate (FITC)-conju-
gated phalloidin (Molecular Probes, Eugene, OR)
was used at a 1/1000 dilution. Primary antibodies
were detected with 5 Wg/ml Texas red-conjugated
anti-mouse or FITC-conjugated anti-rabbit second-
ary antibodies (Jackson Immunoresearch Laborato-
ries). After incubation with secondary antibody, the
coverslips were washed three times for 5 min with
PBS and mounted on microscope slides for viewing
and photography.
2.5. Protein association and immunoblotting
Cells were lysed at 48 h post transfection in modi-
¢ed radioimmunoprecipitation assay bu¡er (RIPA)
(150 mM NaCl, 50 mM HEPES, pH 7.5, 1% Non-
idet P-40, 0.5% sodium deoxycholate) containing
protease and phosphatase inhibitors (50 Wg/ml leu-
peptin, 100 Wg/ml phenylmethylsulfonyl £uoride,
0.045 TIU/ml aprotinin, 1 mM sodium vanadate,
and 40 mM sodium £uoride). Protein concentrations
were determined using the BCA assay (Pierce).
For in vitro association experiments, GST fusion
proteins were expressed in bacteria and a⁄nity-puri-
¢ed using glutathione-Sepharose (Pharmacia) [43].
Fusion proteins were incubated at a ¢nal concentra-
tion of 250 nM with lysate for 1 h at 4‡C. For asso-
ciation of the CAS SH3 domain with FAK, 500 Wg
of CE cell lysate was used. For association with
FAK and Src GST fusion proteins, ectopic CAS
molecules were produced by transient transfection,
and the amount of lysate used for incubation was
determined empirically from immunoblots performed
to assess protein expression. After incubation, the
beads were washed twice with modi¢ed RIPA and
twice with HEPES-bu¡ered saline (50 mM HEPES,
pH 7.5, 150 mM NaCl). Associated proteins were
eluted by boiling in Laemmli sample bu¡er, resolved
by either 8% or 12% sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis (SDS-PAGE), and trans-
ferred to nitrocellulose for immunoblotting. Immu-
noblotting was carried out using mAb 9E10 at a
concentration of 0.2 Wg/ml, or BC3 at a 1/1000 dilu-
tion. The primary antibody was detected using horse-
radish peroxidase (HRP)-conjugated rabbit anti-
mouse IgG or HRP-conjugated protein A, followed
by enhanced chemiluminescence (ECL; Amersham).
3. Results
To determine the requirements for targeting CAS
to focal adhesions, epitope-tagged variants of CAS
were expressed in REF52 cells, either by microinjec-
tion or by transient transfection, and their subcellu-
lar localization was determined by immuno£uores-
cence. As shown in Fig. 2, co-staining of cells with
a myc-speci¢c mAb (Fig. 2A) and CAS-speci¢c poly-
clonal antisera (CAS-F) (Fig. 2B) revealed that the
majority of ectopically expressed full-length CAS was
appropriately targeted to focal adhesions. The stain-
ing of CAS was coincident with that of FAK, as
shown by co-staining with BC3, a FAK-speci¢c poly-
clonal antisera (compare Fig. 2C and D). Co-staining
with FITC-phalloidin, which decorates actin stress
¢bers, con¢rmed that CAS localized to the end of
stress ¢bers (Fig. 2E,F). The speci¢city of this local-
ization was con¢rmed by the fact that focal adhesion
staining was not observed when secondary antibody
was used alone (data not shown). Nuclear and/or
perinuclear staining of ectopic CAS was occasionally
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observed, but the extent and quality of this staining
varied from transfection to transfection. Finally, the
majority of full-length CAS was also recruited to
focal adhesions when expressed by retroviral infec-
tion of CE cells (data not shown).
3.1. The SH3 domain of CAS is targeted to focal
adhesions
We and others have previously shown that the
SH3 domain of CAS associates with FAK [4,11].
Filter binding far-Western assays have revealed that
the tyrosine phosphatase PTP-PEST can also associ-
ate with CAS via its SH3 domain [12]. In addition,
the tyrosine phosphatase PTP1B and the guanine nu-
cleotide exchange factor C3G have been reported to
interact with the CAS SH3 domain [13,14]. However,
PTP-PEST, PTP-1B, and C3G are all cytoplasmic
proteins, and thus are unlikely to play a role in tar-
geting CAS to focal adhesions. To determine whether
the SH3 domain of CAS localized to focal adhesions,
and if its association with speci¢c focal adhesion
proteins such as FAK was critical for this localiza-
tion, wild-type and mutated versions of the CAS
SH3 domain were generated (Fig. 1). The mutant
SH3 (E21Q) domain contained a substitution of a
conserved acidic residue that has been shown to be
important in mediating the association of other SH3
domains with their partner proteins [44].
To verify that the E21Q substitution prevented the
CAS SH3 domain from binding to FAK, an in vitro
association assay was carried out. GST, and GST
fusions of both the wild-type and mutant SH3 do-
mains, were expressed in bacteria and puri¢ed using
glutathione-Sepharose as described in Section 2 (Fig.
3A). CE lysate was incubated with the puri¢ed pro-
teins, and association with FAK was detected by
immunoblotting with BC3, a polyclonal antisera spe-
ci¢c for the C terminus of FAK (Fig. 3B). Only the
wild-type SH3 domain was able to associate with
FAK (lane 3). These data con¢rm that the E21Q
amino acid substitution was su⁄cient to prevent
Fig. 3. Characterization and expression of the CAS SH3 and SH3(E21Q) domains. (A) GST fusion proteins were expressed in Escheri-
chia coli, puri¢ed, and quantitated by Coomassie stain. (B) Association of FAK with CAS SH3 domain molecules. The indicated
GST fusion proteins were incubated with 500 Wg of CE lysate. Associated proteins were eluted by boiling in Laemmli sample bu¡er
and immunoblotted with FAK-speci¢c BC3 polyclonal antibodies. For comparison, 25 Wg cell lysate was also immunoblotted (lane 1).
(C) Constructs encoding myc-tagged SH3 and SH3(E21Q) domains were transfected into REF52 cells, and 50Wg of cell extract was
immunoblotted with myc mAb 9E10.
Fig. 2. CAS expressed in REF52 cells is targeted to focal adhe-
sions. REF52 cells expressing myc-tagged CAS were ¢xed and
co-stained with myc-speci¢c mAb 9E10 (A,C,E) and either
CAS-speci¢c polyclonal antibodies CAS-F (B), FAK-speci¢c
BC3 polyclonal antibodies (D), or FITC-phalloidin (F).
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the interaction between FAK and the SH3 domain of
CAS.
To determine the subcellular localization of the
wild-type and E21Q SH3 domains, the correspond-
ing myc-tagged constructs were expressed in REF52
cells. The amino acid substitution at residue 21 ap-
peared to have no e¡ect on protein expression or
stability, as similar levels of protein were detected
by immunoblot following transfection of these con-
structs (Fig. 3C). Co-staining with a myc-speci¢c
antibody and phalloidin showed that the wild-type
SH3 domain was targeted to focal adhesions (Fig.
4A,B). This was also the case when the SH3 domain
was expressed in CE cells (data not shown). How-
ever, introduction of the E21Q mutation, which ren-
dered the SH3 domain unable to associate with
FAK, prevented localization of the SH3 domain to
focal adhesions (Fig. 4C,D).
3.2. The SH3 domain is not required for CAS
localization to focal adhesions
To determine whether a functional SH3 domain
was necessary for targeting CAS to focal adhesions,
the E21Q amino acid substitution was introduced
into full-length CAS (Fig. 1). To ensure that the
E21Q substitution inhibited CAS-FAK interactions
when it was placed in the context of the entire
CAS molecule, cell lysates containing ectopic wild-
type CAS or CAS(E21Q) were incubated with a
GST fusion of the C terminus of FAK (CtermII).
Unlike wild-type CAS, the CAS(E21Q) molecule
showed no association with GST-CtermII(FAK)
(Fig. 5A, compare lanes 1 and 2), even though it
was e⁄ciently expressed (Fig. 5B, lane 2). However,
in contrast to the marked inhibitory e¡ect of this
mutation on the localization of the independent
SH3 domain (Fig. 4C), the E21Q mutation had al-
most no inhibitory e¡ect on the ability of full-length
CAS to be localized to focal adhesions (Fig. 6A,B).
To further investigate the role of the SH3 domain
in the localization of CAS to focal adhesions, two
variants of CAS were generated in which the SH3
domain alone (vSH3), or the SH3 domain in con-
junction with the adjoining proline-rich region
(vSH3/Pro), were deleted (Fig. 1). These variants
Fig. 4. The SH3 domain of CAS, but not SH3(E21Q), is targeted to focal adhesions. REF52 cells expressing a myc-tagged version of
the CAS SH3 domain (A,B), or the CAS SH3 domain containing the E21Q amino acid substitution that rendered it unable to associ-
ate with FAK (C,D), were ¢xed and co-stained with myc-speci¢c mAb 9E10 (A,C) and FITC-phalloidin (B,D).
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were produced at their predicted molecular weights
(Fig. 5B, lanes 4 and 5), and as expected, neither
protein was able to associate with the C terminus
of FAK (Fig. 5A, lanes 4 and 5). Like the E21Q
amino acid substitution, neither of these deletions
inhibited CAS from being targeted to focal adhesions
(Fig. 6C^F). These data indicate that, in the absence
of a functional SH3 domain that promotes interac-
tions with FAK and other SH3 binding proteins,
CAS was still targeted to focal adhesions.
3.3. The Src binding sites on CAS are not required for
CAS localization to focal adhesions
A second focal adhesion-localized protein that has
been shown to associate with CAS is c-Src (Src). The
SH3 and SH2 domains of Src interact with their
respective consensus binding sites 639RPLPSPP and
668YDYV located in the C terminus of CAS (Fig. 1)
[15]. To determine whether Src played a role in local-
izing CAS to focal adhesions, two amino acid sub-
stitutions, P642A and Y668F, were made in the con-
text of a CAS molecule that also contained the E21Q
mutation (Fig. 1). These mutations resulted in the
generation of a variant of CAS that was unable to
associate with either FAK (Fig. 5A, lane 3) or the
Src SH3 domain (Fig. 5C, lane 3), as measured in a
pulldown assay. It was not possible to test whether
these amino acid substitutions also rendered the mol-
ecule unable to bind to the Src SH2 domain because
even ectopically expressed wild-type CAS was not
found to associate with the Src SH2 domain under
the conditions used for the pulldown assay (data not
shown). Immunostaining of REF52 cells expressing
the CAS(E21Q/P642A/Y668F) variant with myc
antibodies revealed that this molecule still retained
the ability to be targeted to focal adhesions (Fig.
7A,B). This suggests that another, as yet unidenti-
¢ed, region of CAS was important for targeting
CAS to focal adhesions.
3.4. The carboxy terminus of CAS contains focal
adhesion targeting sequences
In order to de¢ne other regions of CAS that were
involved in mediating its localization to focal adhe-
sions, additional CAS variants were generated. Ami-
Fig. 5. Association of CAS variants with FAK and Src. 293
cells were transfected with cDNAs expressing the indicated con-
structs and lysed 48 h later. (A) Association of CAS variants
with FAK. GST fusions composed of the C terminus of FAK
[CtermII(FAK)] were incubated with lysate at concentrations
normalized for equivalent expression of the various constructs.
Associated proteins were eluted by boiling in Laemmli sample
bu¡er and immunoblotted with the myc mAb 9E10. (B) Expres-
sion of ectopic CAS molecules. In parallel, transfected cell ex-
tracts were immunoblotted with myc mAb 9E10 in order to
document expression of each protein. (C) Association of CAS
variants with the Src SH3 domain. A GST fusion of the SH3
domain of Src was incubated with the indicated lysates, and as-
sociated proteins were eluted and immunoblotted with the myc
mAb 9E10.
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no acid residues 119^421 were deleted from CAS to
produce a molecule that lacked the substrate binding
YXXP domain (vYXXP) (Fig. 1). Deletion of this
region did not a¡ect the targeting of CAS to focal
adhesions (Fig. 7C,D). Correspondingly, when the
YXXP domain was expressed as a discrete protein
in both REF52 and CE cells, it remained cytoplasmic
(data not shown), thus con¢rming that this domain
was not involved in targeting CAS to focal adhe-
sions.
To determine whether C-terminal sequences were
important for CAS localization, two deletions,
vCT(546^874) and vCT(693^874), were generated
(Fig. 1). The larger C-terminal deletion was made
either in the context of wild-type CAS, or in CAS
containing the E21Q mutation located in the SH3
domain. As expected, the vCT(546^874) molecule
that contained the SH3 domain mutation was unable
to interact with GST-CtermII(FAK) (Fig. 5A, lane
7). Both C-terminal deletions of CAS severely atten-
uated the ability of CAS to become localized to focal
adhesions (Fig. 8A^D), and in the context of the
E21Q mutation, focal adhesion localization was com-
pletely inhibited (Fig. 8E,F). These data indicated
Fig. 6. The SH3 domain is not required for localization of CAS to focal adhesions. cDNAs encoding CAS containing the amino acid
substitution E21Q (A,B), or variants deleted in either the SH3 domain (C,D) or the SH3 domain and the adjoining proline domain
(E,F) were expressed in REF52 cells. The cells were ¢xed and co-stained with myc-speci¢c mAb 9E10 (A,C,E) and either FITC-phal-
loidin (B,D), or FAK polyclonal BC3 antibodies (F).
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that a second focal adhesion localization sequence
was located in the C terminus of CAS.
The extreme C terminus of CAS is highly con-
served between CAS family members and contains
a helix-loop-helix motif. The region of CAS begin-
ning at amino acid residue 693 and continuing to the
end of the molecule was identi¢ed as a functional
domain in HEF1 responsible for inducing pseudohy-
phal growth [7]. As deletion of this region severely
attenuated focal adhesion targeting of CAS (Fig.
8C,D), a myc-tagged protein composed of amino
acids 693^874 was generated (CT[693^874]) (Fig.
1). This small 182 amino acid protein was found to
localize very e⁄ciently to focal adhesions when it
was expressed in REF52 cells (Fig. 8G,H). Taken
together, these data identify a novel function for
the extreme C terminus of CAS as a focal adhesion
targeting sequence.
4. Discussion
Focal adhesion assembly involves the coordinated
recruitment of its various component proteins. Upon
ligand binding and clustering of integrins, proteins
appear to assemble into focal adhesions in a stepwise
manner [45]. In this report, we demonstrate that the
recruitment of CAS to focal adhesions is regulated
by two separate signals. Both the SH3 domain and a
182 amino acid region at the extreme C terminus of
CAS localized to focal adhesions when expressed as
discrete proteins. Deletion or inactivation of the SH3
domain in the context of full-length CAS did not
dramatically inhibit the localization of CAS to focal
adhesions. In contrast, deletion of residues 546^874
or 693^874 severely attenuated the targeting of CAS
to focal adhesions, and the functional inactivation of
both the SH3 domain and the C terminus totally
inhibited CAS localization to these structures. The
regulated targeting of CAS to focal adhesions by
two independent domains may re£ect the important
Fig. 7. Neither the Src binding sites on CAS, nor the substrate binding YXXP domain is required for localization of CAS to focal ad-
hesions. cDNAs encoding a CAS variant containing amino substitutions E21Q, P642A and Y668F (A,B), and a variant of CAS de-
leted in the substrate binding YXXP domain (C,D), were expressed in REF52 cells, ¢xed, and co-stained with mAb 9E10 (A,C) and
either FITC-phalloidin (B), or FAK polyclonal BC3 antibodies (D).
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role of CAS in mediating focal adhesion formation
and migration [22,27^29,31,33,34].
In a previous study, it was reported that deletion
of the SH3 domain was su⁄cient to prevent CAS
localization to focal adhesions in continuously adher-
ent COS-1 cells [35]. In this study, we also found that
the SH3 domain played a role in targeting CAS to
focal adhesions in REF52 and CE cells. However,
Fig. 8. The C terminus of CAS exhibits focal adhesion targeting activity. cDNAs encoding a deletion of the CAS C terminus begin-
ning at amino acid 546 (A,B), a deletion of the CAS C terminus beginning at amino acid 693 (C,D), a deletion of the CAS C termi-
nus in the context of the SH3 inactivating amino acid substitution E21Q (E,F), and the isolated C terminus consisting of the ¢nal 182
amino acids of CAS (G,H) were expressed in REF52 cells, ¢xed, and co-stained with mAb 9E10 (A,C,E,G) and FITC-phalloidin
(B,D,F,H).
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using three di¡erent constructs that either deleted or
abrogated the function of the SH3 domain, we dem-
onstrated that the SH3 domain was not absolutely
required for CAS localization to focal adhesions.
Discrepancies between our study and the report by
Nakamoto et al. may have arisen as a consequence
of di¡erences in the position of the epitope tag that
was engineered onto each of the CAS constructs.
Whereas the studies described in this report were
performed using CAS molecules that contained an
N-terminal Myc epitope tag, Nakamoto et al. used
a C-terminal hemagglutinin (HA) epitope tag. If the
presence of this C-terminal tag prevented proper
folding of the helix-loop-helix motif or other confor-
mationally sensitive functional motifs in the C termi-
nus, then the ability of this region of CAS to func-
tion as a focal adhesion targeting signal may have
been compromised.
The SH3 domain of CAS has the capacity to bind
to the focal adhesion protein FAK, as well as to
several cytoplasmic proteins including PTP-PEST,
PTP1B, and C3G [4,11^14]. The main function of
the association of CAS with FAK may be in the
recruitment of CAS to focal adhesions, particularly
since Src appears to be primarily responsible for the
adhesion-dependent tyrosine phosphorylation of
CAS [19^21]. A second focal adhesion protein that
may play a role in CAS localization is Src. To inves-
tigate further the role of Src in CAS localization,
mutations at both the Src SH2 and SH3 binding sites
were made in the context of CAS molecules that
contained the E21Q SH3 inactivating mutation. In
spite of its inability to bind to either Src or FAK,
this molecule was still able to localize to focal adhe-
sions. These data suggest that, in continuously ad-
herent cells, CAS localization to focal adhesions does
not require its physical interaction with Src.
Our results reveal a critical role for a 182 amino
acid region at the extreme C terminus of CAS in the
localization of CAS to focal adhesions. This domain
constitutes one of the most highly conserved regions
shared by CAS family members, and thus is likely to
serve an important function. It corresponds exactly
to the region in the CAS family member HEF1 that
was found to cause enhanced pseudohyphal growth
in Saccharomyces cerevisiae [7]. Expression of this
182 amino acid region from CAS also resulted in
pseudohyphal growth in yeast, although to a lesser
extent than HEF1 [7]. Structurally, this region is pre-
dicted to contain a helix-loop-helix motif, and it has
been shown to facilitate HEF1 homodimerization
and heterodimerization between HEF1 and CAS
[10]. The possible function of this region as a dimer-
ization motif suggests a model in which CAS mole-
cules may ¢rst be recruited to focal adhesions via
interactions with the SH3 domain, and these mole-
cules may then bind to additional CAS molecules
and other focal adhesion proteins via dimerization.
However, we were unable to show interactions be-
tween a GST fusion protein that spanned the C-ter-
minal focal adhesion targeting region of CAS (amino
acid residues 693^874) and the focal adhesion pro-
teins vinculin, paxillin, tensin, talin, or CAS in in
vitro pulldown assays (data not shown; M.R. Burn-
ham and AHB, unpublished results). The NSP family
of adapter molecules has been shown to interact with
the C terminus of CAS, and NSP3/Chat colocalizes
with CAS at membrane ru¥es [25,26]. It is therefore
possible that these proteins may play a role in the
recruitment of CAS to focal adhesions.
The two focal adhesion targeting regions of CAS
identi¢ed in this report are highly conserved among
the three family members, CAS, HEF1 and Efs/Sin.
This would suggest that all three family members
should be localized to focal adhesions. To date, the
subcellular localization of Efs/Sin has not been re-
ported. HEF1 exists as three species (p115HEF1,
p105HEF1, and p55HEF1) whose expression is dif-
ferentially regulated throughout the cell cycle [46].
Like CAS, the p105HEF1 and p115HEF1 species
are predominantly associated with focal adhesions.
p55HEF1 encompasses the amino-terminal half of
HEF1, and is produced at the beginning of mitosis
by caspase-mediated cleavage of full-length HEF1.
Despite the presence of the SH3 domain in
p55HEF1, however, it becomes associated with the
mitotic spindle. It has been proposed that the cas-
pase-mediated removal of full-length HEF1 from fo-
cal adhesions may be an important step in disrupting
integrin-mediated signaling at the start of mitosis
[47]. A recent study [48] has shown that CAS can
also be cleaved by caspase 3. During etoposide-in-
duced apoptosis, caspase cleavage of CAS produces
a 47 kDa and 31 kDa fragment. The 31 kDa frag-
ment (residues 654^874) corresponds approximately
to the C-terminal fragment shown in this report to
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contain focal adhesion targeting sequences (residues
693^874). Since caspase-mediated cleavage of CAS
was shown to correlate with the loss of focal adhe-
sions in apoptotic cells, it has been proposed that
CAS cleavage contributes to the disassembly of focal
adhesions.
Our results support a model whereby the SH3 and
C-terminal conserved regions of CAS family mem-
bers act as interaction domains for proteins that dic-
tate their subcellular localization. It has been shown
that, in many cases, tyrosine phosphorylation of
CAS correlates with its movement to focal adhesions
[28]. Once within focal adhesions, CAS may be resis-
tant to the e¡ects of cytoplasmic tyrosine phospha-
tases such as PTP-PEST, and accessible to protein
tyrosine kinases such as Src. This would ultimately
lead to increased tyrosine phosphorylation of CAS.
The third conserved domain within the CAS family
of proteins is the substrate binding YXXP domain,
which contains a cluster of potential phosphorylation
sites that can interact with SH2 containing proteins.
The recruitment of signaling and structural proteins
to these SH2 binding sites would then contribute to
known functions of CAS within focal adhesions,
such as focal adhesion formation [27^29], actin ¢la-
ment polymerization [32], and cell migration
[22,31,33,34].
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